LIVE

Serial Number

88390818

Owner

Acro Biotech Inc.

Attorney

Samantha C. Markley

First Use Date

Mar 30, 2019

Filing Date

Apr 17, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

APOKI Trademark

Serial Number: 88390818 • Registration: 6297837

APOKI is a trademark filed by Acro Biotech Inc. on April 17, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Acro Biotech Inc. (11 trademarks)

Montclair, CA 91763

Entity Type: 03

Legal Representation

Attorney of Record

Samantha C. Markley

1,948 trademarks filed View all →

Correspondence Address

Acro Biotech Inc.

9500 7th St Suite M

Rancho Cucamonga, CA 91730

United States

Trademark Details

Filing Date

April 17, 2019

Registration Date

March 23, 2021

First Use Anywhere

March 30, 2019

First Use in Commerce

March 30, 2019

Published for Opposition

October 6, 2020

Goods & Services

Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in diseases testing

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Mar 23, 2026 REM1

WITHDRAWAL OF ATTORNEY GRANTED

Sep 29, 2025 WOAG

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Sep 29, 2025 WOAR

REGISTERED-PRINCIPAL REGISTER

Mar 23, 2021 R.PR

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Feb 14, 2021 ETOP

EXTENSION OF TIME TO OPPOSE RECEIVED

Oct 23, 2020 ETOF

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 6, 2020 NPUB

PUBLISHED FOR OPPOSITION

Oct 6, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 16, 2020 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 31, 2020 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 19, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 19, 2020 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Aug 17, 2020 ERFR

NOTIFICATION OF FINAL REFUSAL EMAILED

Apr 23, 2020 GNFN

FINAL REFUSAL E-MAILED

Apr 23, 2020 GNFR

FINAL REFUSAL WRITTEN

Apr 23, 2020 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 16, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 16, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 14, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 11, 2019 GNRN

NON-FINAL ACTION E-MAILED

Nov 11, 2019 GNRT

NON-FINAL ACTION WRITTEN

Nov 11, 2019 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 16, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 16, 2019 CRFA

ASSIGNED TO LIE

Aug 16, 2019 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 8, 2019 TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 6, 2019 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 5, 2019 GNRN

NON-FINAL ACTION E-MAILED

Aug 5, 2019 GNRT

NON-FINAL ACTION WRITTEN

Aug 5, 2019 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 14, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 14, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 14, 2019 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 8, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jun 8, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jun 8, 2019 CNRT

ASSIGNED TO EXAMINER

Jun 5, 2019 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 7, 2019 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 4, 2019 NWOS

NEW APPLICATION ENTERED

Apr 20, 2019 NWAP

Related Trademarks

More from this Owner

BEACAN

INSTEST

BEACAN

OPTILYTE

DIABEPRO

More in Same Class